ING Group’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-145,000
Closed -$1.04M 784
2019
Q2
$1.04M Buy
145,000
+57,068
+65% +$409K 0.02% 373
2019
Q1
$1.17M Sell
87,932
-29,500
-25% -$392K 0.03% 293
2018
Q4
$924K Buy
+117,432
New +$924K 0.02% 346